hard to say without knowing the costs involved, but on the face of it, i don't think it's a good idea. you are just adding to the costs of trials.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
